# Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA

> **NCT01139658** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1676 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01139658
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 1676 (ACTUAL)
- **Last updated:** 2014-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01139658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01139658, "Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01139658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*